| __timestamp | Supernus Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 4101058 |
| Thursday, January 1, 2015 | 29135000 | 10763215 |
| Friday, January 1, 2016 | 42791000 | 5579049 |
| Sunday, January 1, 2017 | 49577000 | 32051299 |
| Monday, January 1, 2018 | 89209000 | 24482286 |
| Tuesday, January 1, 2019 | 69099000 | 43892589 |
| Wednesday, January 1, 2020 | 75961000 | 44505000 |
| Friday, January 1, 2021 | 90467000 | 79406000 |
| Saturday, January 1, 2022 | 74552000 | 49283000 |
| Sunday, January 1, 2023 | 91593000 | 17282730 |
Cracking the code
In the dynamic world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Verona Pharma plc and Supernus Pharmaceuticals, Inc. have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Supernus Pharmaceuticals consistently outpaced Verona Pharma in R&D spending, peaking in 2023 with a 367% increase from 2014. Verona Pharma, while showing a significant 321% rise in R&D expenses from 2014 to 2021, experienced a notable dip in 2023, reducing its R&D budget by 56% compared to the previous year. This divergence highlights Supernus's commitment to sustained innovation, while Verona's fluctuating investments suggest a more strategic, perhaps cautious, approach. As the pharmaceutical landscape evolves, these investment patterns could shape the future of drug development and market leadership. Stay tuned to see how these strategies impact their competitive edge in the coming years.
"R&D Investment Trends: Verona vs. Supernus Pharmaceuticals"
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.